TERT and glioblastoma: The composition of TERT mutations within the entire glioblastoma cohort (n = 101) included promoter mutations (n = 89; 88.12%), promoter mutations in the setting of TERT amplification (n = 9; 8.91%), and missense mutations (n = 3; 2.97%).